JiangXi ChangJiu Biochemical Industry Co., Ltd. Provides Earnings Guidance for the First Half of Fiscal Year 2019
July 26, 2019
Share
JiangXi ChangJiu Biochemical Industry Co., Ltd. provided earnings guidance for the first half of fiscal year 2019. For the first half, the company predicts that it will suffer a loss in its net profit belonging to shareholders of the listed company in the first half of 2019 compared with RMB 3,714,100 in the same period of the year before, with the net loss belonging to shareholders of the listed company to be between RMB 5.5 million and RMB 4.5 million, from positive to negative. The company predicts that it will suffer a loss in its net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss in the first half of 2019 compared with RMB 3,368,100 in the same period of the year before, with the net loss belonging to shareholders of the listed company after excluding extraordinary profit and loss to be between RMB 5.67 million and RMB 4.67 million, from positive to negative.
Fanli Digital Technology Co Ltd, formerly Jiangxi Fanli Digital Technology Co Ltd, is a China-based company principally engaged in the manufacture and distribution of acrylamide and other chemical products. The Company's other chemical products include urea, crude methanol, synthetic ammonia, silica hydrated, liquid carbon dioxide, plastic pipes, polyacrylamide, hydrogen, nitrogen and oxygen, among others. The Company distributes its products primarily in domestic market.
FANLI DIGITAL TECHNOLOGY CO.,LTD 
